跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Oncopeptides Ab
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 11, 2023
Approval ID
e8e0f5d5a6fc0de0
Company
Oncopeptides Ab
Type
Standard
Approval Details
Approval Id
e8e0f5d5a6fc0de0
Drug Cima Aemps Name
PEPAXTI 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1221669001
Holder Company Name
Oncopeptides Ab
Marketing Company Name
Oncopeptides Ab
Holder Company Detail Path
/organization/oncopeptides-ab
Marketing Company Detail Path
/organization/oncopeptides-ab
Authorization Date
2023-09-11
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
20 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Oncopeptides Ab
Company Detail Path
/organization/oncopeptides-ab
Company Information
Pharmaceutical Company Name
Oncopeptides Ab
Country Name
Belgium
City Name
unknown,unknown,country_be
Address
Unknown Belgian address
Website
http://www.oncopeptides.se
Active Ingredients
MELFALAN FLUFENAMIDA HIDROCLORURO
21,48 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 11, 2023
Approval ID
e8e0f5d5a6fc0de0
Type
Standard
Back to CIMA-AEMPS Approvals